1. Home
  2. CLDX vs BATRK Comparison

CLDX vs BATRK Comparison

Compare CLDX & BATRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$38.90

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Atlanta Braves Holdings Inc. Series C

BATRK

Atlanta Braves Holdings Inc. Series C

HOLD

Current Price

$49.70

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
BATRK
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.4B
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
CLDX
BATRK
Price
$38.90
$49.70
Analyst Decision
Strong Buy
Buy
Analyst Count
10
2
Target Price
$46.60
$60.00
AVG Volume (30 Days)
694.0K
498.1K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.00
EPS
N/A
N/A
Revenue
$12,743,000.00
$732,492,000.00
Revenue This Year
$111.39
$12.40
Revenue Next Year
$235.85
$8.54
P/E Ratio
N/A
N/A
Revenue Growth
87.78
10.52
52 Week Low
$22.10
$37.76
52 Week High
$45.14
$54.46

Technical Indicators

Market Signals
Indicator
CLDX
BATRK
Relative Strength Index (RSI) 44.63 41.69
Support Level $28.51 $48.57
Resistance Level $40.30 $52.46
Average True Range (ATR) 1.37 1.14
MACD -0.36 -0.22
Stochastic Oscillator 9.94 18.51

Price Performance

Historical Comparison
CLDX
BATRK

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: